Moreover, the percentage of P-STAT3+CD8+ T cells in total CD8+ T cells was found increased in PB of CRC patients vs. HDs and advanced-stage patients vs. early-stage patients (Supplementary Figure 3). This evidence concerns the gene STAT3 and colorectal carcinoma.